218 related articles for article (PubMed ID: 25081058)
21. Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.
Villa F; Deak M; Bloomberg GB; Alessi DR; van Aalten DM
J Biol Chem; 2005 Mar; 280(9):8180-7. PubMed ID: 15611135
[TBL] [Abstract][Full Text] [Related]
22. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
[TBL] [Abstract][Full Text] [Related]
23. An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.
Xia W; Petricoin EF; Zhao S; Liu L; Osada T; Cheng Q; Wulfkuhle JD; Gwin WR; Yang X; Gallagher RI; Bacus S; Lyerly HK; Spector NL
Breast Cancer Res; 2013; 15(5):R85. PubMed ID: 24044505
[TBL] [Abstract][Full Text] [Related]
24. Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2.
Ren L; Chen X; Luechapanichkul R; Selner NG; Meyer TM; Wavreille AS; Chan R; Iorio C; Zhou X; Neel BG; Pei D
Biochemistry; 2011 Mar; 50(12):2339-56. PubMed ID: 21291263
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
26. Structure of an SspH1-PKN1 complex reveals the basis for host substrate recognition and mechanism of activation for a bacterial E3 ubiquitin ligase.
Keszei AF; Tang X; McCormick C; Zeqiraj E; Rohde JR; Tyers M; Sicheri F
Mol Cell Biol; 2014 Feb; 34(3):362-73. PubMed ID: 24248594
[TBL] [Abstract][Full Text] [Related]
27. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
Zhao D; Lu X; Wang G; Lan Z; Liao W; Li J; Liang X; Chen JR; Shah S; Shang X; Tang M; Deng P; Dey P; Chakravarti D; Chen P; Spring DJ; Navone NM; Troncoso P; Zhang J; Wang YA; DePinho RA
Nature; 2017 Feb; 542(7642):484-488. PubMed ID: 28166537
[TBL] [Abstract][Full Text] [Related]
28. Lysine 63-linked polyubiquitination is required for EGF receptor degradation.
Huang F; Zeng X; Kim W; Balasubramani M; Fortian A; Gygi SP; Yates NA; Sorkin A
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15722-7. PubMed ID: 24019463
[TBL] [Abstract][Full Text] [Related]
29. Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression.
Xia X; Hu T; He X; Liu Y; Yu C; Kong W; Liao Y; Tang D; Liu J; Huang H
Int J Biol Sci; 2023; 19(2):377-392. PubMed ID: 36632463
[TBL] [Abstract][Full Text] [Related]
30. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
Marx C; Held JM; Gibson BW; Benz CC
Cancer Res; 2010 May; 70(9):3709-17. PubMed ID: 20406983
[TBL] [Abstract][Full Text] [Related]
31. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
Hu J; Hubbard SR
J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
[TBL] [Abstract][Full Text] [Related]
32. Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data.
Kumar N; Wolf-Yadlin A; White FM; Lauffenburger DA
PLoS Comput Biol; 2007 Jan; 3(1):e4. PubMed ID: 17206861
[TBL] [Abstract][Full Text] [Related]
33. HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cells.
Iaconelli J; Huang JH; Berkovitch SS; Chattopadhyay S; Mazitschek R; Schreiber SL; Haggarty SJ; Karmacharya R
ACS Chem Biol; 2015 Mar; 10(3):883-90. PubMed ID: 25546293
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of PTPN18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer.
Cai J; Huang S; Yi Y; Bao S
Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):734-742. PubMed ID: 31034093
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the catalytic activity of cell adhesion kinase beta by protein-tyrosine phosphatase-PEST-mediated dephosphorylation.
Lyons PD; Dunty JM; Schaefer EM; Schaller MD
J Biol Chem; 2001 Jun; 276(26):24422-31. PubMed ID: 11337490
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
37. Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.
Zeng F; Xu J; Harris RC
FASEB J; 2009 Jun; 23(6):1935-45. PubMed ID: 19193720
[TBL] [Abstract][Full Text] [Related]
38. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
40. HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.
Gupta P; Gupta N; Fofaria NM; Ranjan A; Srivastava SK
Cancer Lett; 2019 Feb; 442():68-81. PubMed ID: 30409762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
